[AKRO] QoQ Quarter Result on 31-Mar-2019 [#Q1]

Stock
[AKRO] Akero Therapeutics, Inc.
Announcement Date
31-Mar-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- 91.28%
YoY- -1,173.63%
Quarter Report
AKRO's Result
AKRO's Financial Summary
View:
Show?
Quarter Result
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -15,611 -15,554 -7,228 -5,362 -61,472 -11,148 -8,673 47.81%
Tax -46 -16,309 -7,609 -5,362 -2,968 0 -8,662 -96.92%
NP -15,611 -15,554 -7,228 -5,362 -61,472 -11,148 -8,673 47.81%
Tax Rate - - - - - - - -
Total Cost 15,611 15,554 7,228 5,362 61,472 11,148 8,673 47.81%
Ratio Analysis
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
EPS -0.55 -0.56 -2.21 -0.20 -2.90 -0.53 -0.41 21.56%
EPS Diluted -0.55 -0.56 -2.21 -0.20 -2.90 -0.53 -0.41 21.56%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.